Arch Venture Corp »

Boundless Bio shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.7M 2.7M 2.50

More positions owned by Arch Venture Corp

Parabilis Medicines
Beam Therapeutics (BEAM)
Rapport Therapeutics (RAPP)
Seaport Therapeutics Common Stock
Erasca (ERAS)
Vir Biotechnology (VIR)
Maze Therapeatics (MAZE)
Lyell Immunopharma Com New (LYEL)
Generate Biomedicines Com Shs (GENB)
10x Genomics Cl A Com (TXG)
Boundless Bio (BOLD)
Gossamer Bio (GOSS)

View all positions for Arch Venture Corp

Top funds holding Boundless Bio

FMR
Arch Venture Corp
Tang Capital Management
ADAR1 Capital Management
Sectoral Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Sio Capital Management
Stonepine Capital Management
Citadel Advisors

View all funds holding Boundless Bio